Liste des médicaments et vaccins
| DESIGNATION | DCI | TITULAIRE AMM | PAYS D'ORIGINE | PGHT(FCFA) | N°AMM | DATE EXPIRATION AMM |
|---|---|---|---|---|---|---|
| VOLINI 1%+3%+10%+5% Spray pour application cutanée Fl/35 g | DICLOFENAC SODIQUE + HUILE DE LIN + SALICYLATE DE METHYLE + MENTHOL | SUN PHARMACEUTICAL INDUSTRIES LIMITED | Inde | 1147.92 | AMM_2025_19741 | 2031-02-28 |
| STRIMOL 500mg Comprimé effervescent B/16 | PARACETAMOL | STRIDES PHARMA SCIENCE LIMITED. | Inde | 688.75 | AMM_2024_17730 | 2031-02-28 |
| SOVENTUS JUNIOR (0,5mg+10mg+25mg)/5ml Sirop Fl/60 mL | TERBUTALINE + AMBROXOL + GUAIFENESINE | ZUVENTUS HEALTHCARE LIMITED | Inde | 839.62 | AMM_2022_12800 | 2031-02-28 |
| SOVENTUS (1,25mg+20mg+50mg+0,5mg)/5ml Sirop Fl/100 mL | TERBUTALINE + AMBROXOL + GUAIFENESINE + MENTHOL | ZUVENTUS HEALTHCARE LIMITED | Inde | 1115.13 | AMM_2022_12801 | 2031-02-28 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 300mg+5mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 3279.78 | AMM_2025_21105 | 2031-02-28 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 300mg+10mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 3935.74 | AMM_2025_21107 | 2031-02-28 |
| IRBESARTAN/AMLODIPINE BESYLATE IMPACT 150mg+5mg Comprimé pelliculé B/28 | IRBESARTAN + AMLODIPINE | SANOFI-AVENTIS FRANCE | Turquie | 2295.85 | AMM_2025_20942 | 2031-02-28 |
| EXALTO 20mg Comprimé pelliculé B/30 | RIVAROXABAN | EXPHA LTD. | Grèce | 13119.14 | AMM_2025_21689 | 2031-02-28 |
| EXALTO 15mg Comprimé pelliculé B/30 | RIVAROXABAN | EXPHA LTD. | Grèce | 11807.23 | AMM_2025_21738 | 2031-02-28 |
| ESOPEL 20 20mg Comprimé à enrobage entérique B/30 | ESOMEPRAZOLE | MEDOPHARM PRIVATE LIMITED | Inde | 3148.6 | AMM_2025_19328 | 2031-02-28 |